Stocks

Headlines

Viking Therapeutics Sees Bearish Options Activity Amid Price Targets

Investors are expressing a bearish sentiment towards Viking Therapeutics, with notable options trades indicating higher put activity. It raises concerns for retail traders regarding future price movements as they anticipate a price range between $25.0 and $32.5.

Date: 
AI Rating:   4

Investor Sentiment and Options Trading

Viking Therapeutics currently displays a bearish sentiment among large investors, with 62% of options traders favoring this outlook compared to 37% who are bullish. A significant amount of these trades, totaling $315,085 for puts and $67,318 for calls, indicates a cautious stance towards the stock.

The undisclosed nature of the investors—whether institutions or affluent individuals—raises suspicions about underlying information affecting the stock's potential movement. A noticeable amount of put options has been traded, suggesting that these investors are preparing for a decline in stock price.

Price Targets and Stock Performance

Current trading indicates a price of $28.0, representing a slight decrease of 1.23%. Traders are targeting a price range of $25.0 to $32.5 in the coming months. The upcoming earnings release in 33 days may play a crucial role in shaping the stock's trajectory and influencing trader sentiment.

Analysts are cautiously optimistic, with a downgraded rating that still proposes a price target of $102. This discrepancy between retail investor sentiment and analyst forecasts showcases the potential volatility of the stock based on earnings expectations and market reaction.